Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain Injury

Abstract

This study investigates the biokinetics of LGT proteome, a potential biomarker of severe TBI, in serum of severe TBI patients. The LGT proteome presents in the serum of severe TBI patients. The abundance diversity of LGT proteome is closely associated with pathologic condition of TBI patients. Serum LGT proteome may be used as a promising marker for evaluating severity of severe TBI.

Corrigendum to “Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain Injury”

“…Some patients/data were shared between the articles, though there was a different emphasis for each study. The present article [ 1 ] contains the final summary of severe TBI.…”

“…In the article titled “Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain Injury” [ 1 ], there was an incomplete description of how the results related to our earlier publications. The predictive value of LGT in TBI was also overestimated.…”